Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, has announced it has secured £1 million in grant funding from PACE (Pathways to Antimicrobial Clinical Efficacy).
The Infection Innovation Consortium: iiCON is managing a new £3.2 million Medical Research Council funded trial to enable progress into development of a new vaccine against pneumococcal disease.
FUJIFILM Diosynth Biotechnologies has announced that the first phase of its expansion at the Hillerød site is ready to bring the new production capacity into operation.
Editor Rebekah Jordan spoke to Honeywell to explore its long-term supply agreement with DevPro Biopharma to develop a respiratory inhaler that enhances the well-being of patients.
Editor Rebekah Jordan spoke to Kevin Kreutter, Ph.D., senior vice president, Drug Discovery, Empress Therapeutics about how the company is using AI to analyse genetic data, to accelerate and refine small molecule drug discovery.
Lonza announced the completion of the first GMP product batch supported from the recently completed next-generation mammalian manufacturing facility in Portsmouth (US).
PCI is collaborating with theranostics specialist ChiRhoClin, Inc. to avoid the potential shortage of a critical diagnostic drug used to test for pancreatic disease and cancer.
Cytomos has raised £5 million to scale up production of its first commercial product, Celledonia, built on its cell-analysis technology platform AuraCyt.
